WO1997026862A3 - Verbesserte konzentrierte injektions- und infusionslösungen für die intravasale anwendung - Google Patents
Verbesserte konzentrierte injektions- und infusionslösungen für die intravasale anwendung Download PDFInfo
- Publication number
- WO1997026862A3 WO1997026862A3 PCT/DE1997/000170 DE9700170W WO9726862A3 WO 1997026862 A3 WO1997026862 A3 WO 1997026862A3 DE 9700170 W DE9700170 W DE 9700170W WO 9726862 A3 WO9726862 A3 WO 9726862A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- infusion solutions
- intravenous administration
- concentrated injection
- improved concentrated
- injection
- Prior art date
Links
- 239000003978 infusion fluid Substances 0.000 title abstract 3
- 239000007924 injection Substances 0.000 title abstract 3
- 238000002347 injection Methods 0.000 title abstract 3
- 238000001990 intravenous administration Methods 0.000 title 1
- 239000000654 additive Substances 0.000 abstract 2
- 230000001154 acute effect Effects 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 230000003111 delayed effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
- A61K49/0452—Solutions, e.g. for injection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE59710863T DE59710863D1 (de) | 1996-01-25 | 1997-01-27 | Verbesserte kontrastmittenlösungen für die intravasale anwendung |
AT97914098T ATE251893T1 (de) | 1996-01-25 | 1997-01-27 | Verbesserte kontrastmittenlösungen für die intravasale anwendung |
SK1013-98A SK101398A3 (en) | 1996-01-25 | 1997-01-27 | Improved concentrated injection and infusion solutions for intravenous administration |
EP97914098A EP0876140B1 (de) | 1996-01-25 | 1997-01-27 | Verbesserte kontrastmittenlösungen für die intravasale anwendung |
IL12467697A IL124676A0 (en) | 1996-01-25 | 1997-01-27 | Improved concentrated injection and infusion solutions for intravenous use |
AU21504/97A AU2150497A (en) | 1996-01-25 | 1997-01-27 | Improved concentrated injection and infusion solutions for intravenous adminis tration |
PL97328199A PL328199A1 (en) | 1996-01-25 | 1997-01-27 | Improved concentrated intravascular injection and infusion solutions |
DK97914098T DK0876140T3 (da) | 1996-01-25 | 1997-01-27 | Forbedrede kontrastmiddelopløsninger til intravasal anvendelse |
BR9707081A BR9707081A (pt) | 1996-01-25 | 1997-01-27 | Soluções de injeção e infusão concentradas aperfeiçoadas para aplicação intravasal |
CA002244209A CA2244209C (en) | 1996-01-25 | 1997-01-27 | Improved concentrated injection and infusion solutions for intravenous administration |
JP9526441A JP2000505789A (ja) | 1996-01-25 | 1997-01-27 | 注射及び輸液用として血管内に使用する改良された濃縮溶液 |
BG102644A BG62913B1 (bg) | 1996-01-25 | 1998-07-21 | Подобрени концентрирани инжекционни и инфузионни разтвори за интравазално прилагане |
NO983438A NO983438L (no) | 1996-01-25 | 1998-07-24 | Forbedrede konsentrerte injeksjons- og infusjonsl°sninger for intravasal anvendelse |
US09/504,108 US6638913B1 (en) | 1996-01-25 | 2000-02-14 | Concentrated injection and infusion solution for intravenous administration |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19604095 | 1996-01-25 | ||
DE19604095.7 | 1996-01-25 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/504,108 Division US6638913B1 (en) | 1996-01-25 | 2000-02-14 | Concentrated injection and infusion solution for intravenous administration |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1997026862A2 WO1997026862A2 (de) | 1997-07-31 |
WO1997026862A3 true WO1997026862A3 (de) | 1997-10-23 |
Family
ID=7784538
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DE1997/000170 WO1997026862A2 (de) | 1996-01-25 | 1997-01-27 | Verbesserte konzentrierte injektions- und infusionslösungen für die intravasale anwendung |
Country Status (21)
Country | Link |
---|---|
US (1) | US6638913B1 (de) |
EP (1) | EP0876140B1 (de) |
JP (1) | JP2000505789A (de) |
KR (1) | KR100505772B1 (de) |
CN (1) | CN1209751A (de) |
AT (1) | ATE251893T1 (de) |
AU (1) | AU2150497A (de) |
BG (1) | BG62913B1 (de) |
BR (1) | BR9707081A (de) |
CA (1) | CA2244209C (de) |
CZ (1) | CZ234898A3 (de) |
DE (2) | DE19703816A1 (de) |
DK (1) | DK0876140T3 (de) |
ES (1) | ES2208884T3 (de) |
HU (1) | HUP9901355A3 (de) |
IL (1) | IL124676A0 (de) |
NO (1) | NO983438L (de) |
PL (1) | PL328199A1 (de) |
PT (1) | PT876140E (de) |
SK (1) | SK101398A3 (de) |
WO (1) | WO1997026862A2 (de) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6774278B1 (en) | 1995-06-07 | 2004-08-10 | Cook Incorporated | Coated implantable medical device |
EP0996461B1 (de) | 1997-10-31 | 2005-01-12 | Walter Reed Army Institute of Research | Verwendung von inhibitoren der komplementaktivierung zur herstellung eines medikaments zur inhibierung von nebenwirkungen von pharmazeutischen zusammensetzungen, die amphiphile träger oder wirkstoffträger moleküle enthalten |
JP4334766B2 (ja) | 1998-04-01 | 2009-09-30 | カーディオム ファーマ コーポレイション | アミノシクロヘキシルエーテル化合物およびその用途 |
US7057053B2 (en) | 2000-10-06 | 2006-06-06 | Cardiome Pharma Corp. | Ion channel modulating compounds and uses thereof |
US7524879B2 (en) | 2000-10-06 | 2009-04-28 | Cardiome Pharma Corp. | Ion channel modulating compounds and uses thereof |
US8703126B2 (en) | 2000-10-12 | 2014-04-22 | Genentech, Inc. | Reduced-viscosity concentrated protein formulations |
IL155002A0 (en) | 2000-10-12 | 2003-10-31 | Genentech Inc | Reduced-viscosity concentrated protein formulations |
DE10115740A1 (de) | 2001-03-26 | 2002-10-02 | Ulrich Speck | Zubereitung für die Restenoseprophylaxe |
US20020169112A1 (en) * | 2001-05-08 | 2002-11-14 | Luc Montagnier | Combined treatments and methods for treatment of mycoplasma and mycoplasma-like organism infections |
DE10244847A1 (de) | 2002-09-20 | 2004-04-01 | Ulrich Prof. Dr. Speck | Medizinische Vorrichtung zur Arzneimittelabgabe |
DK1560812T3 (da) | 2003-05-02 | 2006-09-04 | Cardiome Pharma Corp | Aminocyclohexyletherforbindelser og anvendelser deraf |
US7345087B2 (en) | 2003-10-31 | 2008-03-18 | Cardiome Pharma Corp. | Aminocyclohexyl ether compounds and uses thereof |
US8058304B2 (en) | 2004-04-01 | 2011-11-15 | Cardiome Pharma Corp. | Merged ion channel modulating compounds and uses thereof |
WO2005113011A2 (en) | 2004-04-01 | 2005-12-01 | Cardiome Pharma Corp. | Prodrugs of ion channel modulating compounds and uses thereof |
WO2006053037A2 (en) | 2004-11-08 | 2006-05-18 | Cardiome Pharma Corp. | A new dosing regimen for ion channel modulating compounds for treating acute atrial fibrillation in a human |
US20060270708A1 (en) * | 2005-05-25 | 2006-11-30 | Navinta Llc | Novel process for preparation of isotonic aqueous injection of ropivacaine |
EP1897535A1 (de) * | 2006-08-30 | 2008-03-12 | Dirinco AG | Substitutionsflüssigkeit für die Haemofiltration |
US20090239894A1 (en) * | 2008-03-20 | 2009-09-24 | Bjorn Schurad | Stabilized aqueous solutions of ergoline compounds |
BRPI1006519A2 (pt) | 2009-03-06 | 2016-08-09 | Genentech Inc | formulação de anticorpos |
US10634741B2 (en) | 2009-12-04 | 2020-04-28 | Endomagnetics Ltd. | Magnetic probe apparatus |
US9427186B2 (en) * | 2009-12-04 | 2016-08-30 | Endomagnetics Ltd. | Magnetic probe apparatus |
SG10201903166PA (en) | 2010-03-01 | 2019-05-30 | Bayer Healthcare Llc | Optimized monoclonal antibodies against tissue factor pathway inhibitor (tfpi) |
CN102319258B (zh) * | 2011-08-04 | 2012-10-31 | 山西诺成制药有限公司 | 一种5%葡萄糖置换液及其制备方法 |
US8613919B1 (en) | 2012-08-31 | 2013-12-24 | Bayer Healthcare, Llc | High concentration antibody and protein formulations |
US9592297B2 (en) | 2012-08-31 | 2017-03-14 | Bayer Healthcare Llc | Antibody and protein formulations |
AU2014229811B2 (en) | 2013-03-11 | 2018-02-15 | Endomagnetics Ltd. | Hypoosmotic solutions for lymph node detection |
US9234877B2 (en) | 2013-03-13 | 2016-01-12 | Endomagnetics Ltd. | Magnetic detector |
US9239314B2 (en) | 2013-03-13 | 2016-01-19 | Endomagnetics Ltd. | Magnetic detector |
KR20150134346A (ko) * | 2013-03-27 | 2015-12-01 | 지이 헬스케어 에이에스 | 진단 조성물을 제조하기 위한 방법 및 시약 |
KR102589814B1 (ko) | 2015-06-04 | 2023-10-13 | 엔도마그네틱스 엘티디 | 자성 표지자 위치 결정(mml)을 위한 표지자 재료 및 형태 |
CA3097061A1 (en) * | 2018-04-16 | 2019-10-24 | Merck Patent Gmbh | Viscosity reduction of highly concentrated protein formulations |
CN110327292A (zh) * | 2019-08-11 | 2019-10-15 | 天津乾丰瑞科技有限公司 | 一种盐酸法舒地尔注射制剂及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2435253A1 (fr) * | 1978-07-04 | 1980-04-04 | Nyegaard & Co As | Procede de preparation d'une solution tamponnee d'une substance de contraste pour rayons x, et produits obtenus par ce procede |
EP0260811A2 (de) * | 1986-08-21 | 1988-03-23 | Vestar, Inc. | Phospholipidpartikeln mit eingeschlossenen Polyen-Antibiotika zur Behandlung von systemischen Pilzinfektionen |
WO1989009614A1 (en) * | 1988-04-15 | 1989-10-19 | Genentech, Inc. | Human growth hormone formulation |
EP0437622A1 (de) * | 1989-07-07 | 1991-07-24 | Kyowa Hakko Kogyo Co., Ltd. | Beständige motilin-herstellung |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE754523A (fr) * | 1969-08-06 | 1971-02-08 | Beecham Group Ltd | Vaccins |
WO1982003773A1 (en) * | 1981-04-27 | 1982-11-11 | Baxter Travenol Lab | Dialysis solution containing glucose,amino acids & insulin |
JPS61502943A (ja) * | 1984-06-22 | 1986-12-18 | ビ−チ、リチャ−ド・エル | 電解質溶液およびその生体内における使用 |
GB8906130D0 (en) * | 1989-03-17 | 1989-05-04 | Nycomed As | Compositions |
DK0437662T3 (da) | 1990-01-18 | 1994-10-17 | Cereria Amos Sgarbi Spa | Gravlys |
GB9020091D0 (en) * | 1990-09-14 | 1990-10-24 | Nycomed As | Contrast media |
DE4135193C1 (de) * | 1991-10-22 | 1993-03-11 | Schering Ag Berlin Und Bergkamen, 1000 Berlin, De | |
IT1256248B (it) * | 1992-12-24 | 1995-11-29 | Bracco Spa | Formulazioni iniettabili acquose per radiodiagnostica comprendenti miscele di composti aromatici iodurati utili come agenti opacizzanti ai raggi x |
WO1995026331A1 (es) * | 1994-03-25 | 1995-10-05 | Centro Investigacion Justesa Imagen, S.A. | Nuevos dimeros iodados no ionicos como agentes de contraste a los rayos x, metodo para su preparacion y composiciones farmaceuticas que los contienen |
DE4446694A1 (de) * | 1994-12-09 | 1996-06-13 | Schering Ag | Verwendung von Zusätzen zu Kontrastmitteln zur Verbesserung der Bildgebung |
-
1997
- 1997-01-27 SK SK1013-98A patent/SK101398A3/sk unknown
- 1997-01-27 IL IL12467697A patent/IL124676A0/xx unknown
- 1997-01-27 AU AU21504/97A patent/AU2150497A/en not_active Abandoned
- 1997-01-27 HU HU9901355A patent/HUP9901355A3/hu unknown
- 1997-01-27 DE DE19703816A patent/DE19703816A1/de not_active Withdrawn
- 1997-01-27 JP JP9526441A patent/JP2000505789A/ja not_active Ceased
- 1997-01-27 WO PCT/DE1997/000170 patent/WO1997026862A2/de not_active Application Discontinuation
- 1997-01-27 DE DE59710863T patent/DE59710863D1/de not_active Expired - Fee Related
- 1997-01-27 CA CA002244209A patent/CA2244209C/en not_active Expired - Fee Related
- 1997-01-27 PT PT97914098T patent/PT876140E/pt unknown
- 1997-01-27 ES ES97914098T patent/ES2208884T3/es not_active Expired - Lifetime
- 1997-01-27 EP EP97914098A patent/EP0876140B1/de not_active Expired - Lifetime
- 1997-01-27 CZ CZ982348A patent/CZ234898A3/cs unknown
- 1997-01-27 KR KR10-1998-0705697A patent/KR100505772B1/ko not_active IP Right Cessation
- 1997-01-27 DK DK97914098T patent/DK0876140T3/da active
- 1997-01-27 PL PL97328199A patent/PL328199A1/xx unknown
- 1997-01-27 AT AT97914098T patent/ATE251893T1/de not_active IP Right Cessation
- 1997-01-27 BR BR9707081A patent/BR9707081A/pt not_active IP Right Cessation
- 1997-01-27 CN CN97191871A patent/CN1209751A/zh active Pending
-
1998
- 1998-07-21 BG BG102644A patent/BG62913B1/bg unknown
- 1998-07-24 NO NO983438A patent/NO983438L/no not_active Application Discontinuation
-
2000
- 2000-02-14 US US09/504,108 patent/US6638913B1/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2435253A1 (fr) * | 1978-07-04 | 1980-04-04 | Nyegaard & Co As | Procede de preparation d'une solution tamponnee d'une substance de contraste pour rayons x, et produits obtenus par ce procede |
EP0260811A2 (de) * | 1986-08-21 | 1988-03-23 | Vestar, Inc. | Phospholipidpartikeln mit eingeschlossenen Polyen-Antibiotika zur Behandlung von systemischen Pilzinfektionen |
WO1989009614A1 (en) * | 1988-04-15 | 1989-10-19 | Genentech, Inc. | Human growth hormone formulation |
EP0437622A1 (de) * | 1989-07-07 | 1991-07-24 | Kyowa Hakko Kogyo Co., Ltd. | Beständige motilin-herstellung |
Also Published As
Publication number | Publication date |
---|---|
IL124676A0 (en) | 1998-12-06 |
US6638913B1 (en) | 2003-10-28 |
KR100505772B1 (ko) | 2005-10-25 |
BG62913B1 (bg) | 2000-11-30 |
SK101398A3 (en) | 1998-12-02 |
DE59710863D1 (de) | 2003-11-20 |
CZ234898A3 (cs) | 1998-11-11 |
EP0876140A2 (de) | 1998-11-11 |
CA2244209C (en) | 2007-10-23 |
PL328199A1 (en) | 1999-01-18 |
DK0876140T3 (da) | 2003-12-15 |
ES2208884T3 (es) | 2004-06-16 |
JP2000505789A (ja) | 2000-05-16 |
DE19703816A1 (de) | 1997-08-07 |
CA2244209A1 (en) | 1997-07-31 |
EP0876140B1 (de) | 2003-10-15 |
HUP9901355A3 (en) | 2000-06-28 |
PT876140E (pt) | 2004-02-27 |
BR9707081A (pt) | 1999-05-25 |
WO1997026862A2 (de) | 1997-07-31 |
BG102644A (en) | 1999-06-30 |
NO983438D0 (no) | 1998-07-24 |
HUP9901355A2 (hu) | 1999-08-30 |
CN1209751A (zh) | 1999-03-03 |
AU2150497A (en) | 1997-08-20 |
ATE251893T1 (de) | 2003-11-15 |
KR19990081979A (ko) | 1999-11-15 |
NO983438L (no) | 1998-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1997026862A3 (de) | Verbesserte konzentrierte injektions- und infusionslösungen für die intravasale anwendung | |
ZA98361B (en) | Hypodermic injection system. | |
AU1011197A (en) | Catheter with fluid medication injectors | |
AU4894197A (en) | Syringe, injector and injector system | |
AU8923398A (en) | Subcutaneous infusion set with dynamic needle | |
EP0604803A3 (en) | Multi purpose perfusion cannula. | |
ZA200100810B (en) | Hypodermic needleless injection system. | |
AU6135399A (en) | Intravenous infusion needle with soft body | |
EP0648511A3 (de) | Injektionsspritze. | |
ZA929225B (en) | Injection syringe. | |
GB9401857D0 (en) | Intravenous infusion set | |
EP0971758A4 (de) | System zur intravenösen infusion | |
ZA99104B (en) | Method for administering ASPB28-human insulin. | |
EP0590757A3 (de) | Sichere Einwegspritze mit zurückziehender selbstvorgespannter Nadel. | |
EP0619423A3 (de) | Krafstoffeinspritzvorrichtung. | |
AU1738197A (en) | Self-destructing injection syringe | |
AU4481599A (en) | Enema syringe, enema syringe auxiliary and injector and enema method using them | |
AU695171B2 (en) | Enrofloxacine injection or infusion solutions | |
AU1404800A (en) | Syringe and coordinated needle set for injections and more specifically for orthodental anesthesia | |
AU4972397A (en) | I.v. catheter with needle guard | |
AU5737094A (en) | Intravenous cannula assembly | |
WO1997024125A3 (fr) | Composition pharmaceutique injectable contenant l'acide ursodesoxycholique ou l'acide tauroursodesoxycholique, une base forte et du trometamol | |
AU6408400A (en) | Tapered intravenous cannula | |
AU5563998A (en) | Injection syringe with needle projecting in the syringe body | |
ZA200107275B (en) | Hypodermic injection system. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 97191871.6 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AU AZ BB BG BR BY CA CN CZ EE GE HU IL IS JP KE KG KP KR KZ LK LR LS LT LV MD MG MK MN MW MX NO NZ PL RO RU SD SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AU AZ BB BG BR BY CA CN CZ EE GE HU IL IS JP KE KG KP KR KZ LK LR LS LT LV MD MG MK MN MW MX NO NZ PL RO RU SD SG KE |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1997914098 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: PV1998-2348 Country of ref document: CZ Ref document number: 1019980705697 Country of ref document: KR Ref document number: 101398 Country of ref document: SK |
|
ENP | Entry into the national phase |
Ref document number: 2244209 Country of ref document: CA Ref document number: 2244209 Country of ref document: CA Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: PV1998-2348 Country of ref document: CZ Ref document number: 1997914098 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1019980705697 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: 1997914098 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1019980705697 Country of ref document: KR |
|
WWR | Wipo information: refused in national office |
Ref document number: PV1998-2348 Country of ref document: CZ |